Affymetrix Price Target Increased to $4.00 by Analysts at Goldman Sachs Group Inc. (AFFX)
Investment analysts at Goldman Sachs Group Inc. boosted their price target on shares of Affymetrix (NASDAQ:AFFX) from $3.70 to $4.00 in a note issued to investors on Friday, Analyst Ratings Network reports. The firm currently has a “sell” rating on the stock. Goldman Sachs Group Inc.’s price objective indicates a potential downside of 34.85% from the stock’s previous close.
Shares of Affymetrix (NASDAQ:AFFX) traded down 0.16% on Friday, hitting $6.14. 384,235 shares of the company’s stock traded hands. Affymetrix has a 1-year low of $2.96 and a 1-year high of $6.51. The stock has a 50-day moving average of $5.68 and a 200-day moving average of $4.49. The company’s market cap is $439.4 million.
Affymetrix (NASDAQ:AFFX) last released its earnings data on Wednesday, July 31st. The company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.05. The company had revenue of $79.46 million for the quarter, compared to the consensus estimate of $78.53 million. During the same quarter in the previous year, the company posted ($0.02) earnings per share. The company’s revenue for the quarter was up 19.7% on a year-over-year basis. On average, analysts predict that Affymetrix will post $0.09 earnings per share for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at Mizuho raised their price target on shares of Affymetrix (NASDAQ:AFFX) from $6.00 to $8.00 in a research note to investors on Monday, September 9th. They now have a “buy” rating on the stock. Separately, analysts at Thomson Reuters/Verus upgraded shares of Affymetrix (NASDAQ:AFFX) from a “hold” rating to a “buy” rating in a research note to investors on Monday, September 2nd. Finally, analysts at Zacks upgraded shares of Affymetrix (NASDAQ:AFFX) from a “neutral” rating to an “outperform” rating in a research note to investors on Thursday, August 29th. They now have a $6.50 price target on the stock. One analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $5.90.
Affymetrix, Inc (NASDAQ:AFFX) is engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.